 LOUGHBOROUGH, England, Dec. 17, 2020 GLOBE NEWSWIRE -- Nemaura Medical, Inc. NASDAQ: NMRD Nemaura or the Company, a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces the official launch of its flagship program, BEATdiabetes, and the availability of its proprietary non-invasive, daily-wear adhesive glucose monitor, proBEATTM. 